Invest now

Indegene share price

Balanced risk
  • 28%Low risk
  • 28%Moderate risk
  • 28%Balanced risk
  • 28%High risk
  • 28%Extreme risk
  • ₹662.30(-0.47%)
    November 16, 2026 15:29:00 PM IST
    • NSE
    • BSE
  • Vol : 797.40 K (NSE + BSE)
    Last 20 day avg : 830.34 K
Indegene is trading -0.47% lower at Rs 662.30 as compared to its last closing price. Indegene has been trading in the price range of 673.35 & 657.70. Indegene has given 28.00% in this year & 9.26% in the last 5 days. Indegene has TTM P/E ratio 34.51 as compared to the sector P/E of 43.19.There are 6 analysts who have initiated coverage on Indegene. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 112.30 Crores in its last quarter.Listed peers of Indegene include Delhivery (-0.67%), Urban Company (1.90%), BLS International Services (-2.14%).The Mutual Fund holding in Indegene was at 12.25% in 30 Sep 2026. The MF holding has decreased from the last quarter. The FII holding in Indegene was at 12.40% in 30 Sep 2026. The FII holding has decreased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Loading...
Key Metrics

Updated on 17 Nov 2026, 12:51 AM IST

  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.05
    In line with industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.34
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    2.69
    Indicates overvaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
Price range
Day Range
Lowest
657.70
Highest
673.35
52 week range
Lowest
414.90
Highest
677.00
Indegene Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Delhivery
439.00-0.6732,894.02226.013.8-11.56
Urban Company
171.901.9026,510.09-8.89-4.87
BLS International Services
224.45-2.149,241.5214.153.940.9513.29
Axiscades Technologies
1,852.80-3.227,889.3983.289.05-23.13
TVS Supply Chain Solutions
137.4512.436,064.6226.672.95-63.67
Mutual Fund Ownership
View all
Invesco India Technology Fund Regular Growth
NA
  • Amount Invested (Cr.) 11.57
  • % of AUM 3.50
Motilal Oswal Digital India Fund Regular Growth
NA
  • Amount Invested (Cr.) 26.15
  • % of AUM 3.29
SBI Long Term Advantage Fund Series VI Regular Plan Growth
NA
  • Amount Invested (Cr.) 6.01
  • % of AUM 2.14
Edelweiss Recently Listed IPO Fund Regular Plan Growth
NA
  • Amount Invested (Cr.) 16.82
  • % of AUM 1.88
SBI Innovative Opportunities Fund Regular Growth
NA
  • Amount Invested (Cr.) 125.45
  • % of AUM 1.70
Indegene Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-10-29Quarterly Results
2026-07-30Quarterly Results
2026-04-29Audited Results & Final Dividend
2026-01-29Quarterly Results & ESOP
2025-10-30Quarterly Results
About the company Indegene
  • IndustryBusiness Services
  • ISININE065X01017
  • BSE Code544172
  • NSE CodeINDGN
Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.
  • Management Info
  • Manish GuptaExecutive Chairman of the Board, Chief Executive Officer
  • Suhas PrabhuChief Financial Officer
  • Sanjay ParikhExecutive Vice President, Executive Director
  • Anand NijegalExecutive Vice President - Global Operations
  • Srishti KaushikCompliance Officer, Company Secretary
  • Viveksheel GhaiExecutive Vice President - Enterprise Commercial Solutions of Indegene, Inc.
  • Gaurav KapoorExecutive Vice President of Indegene, Inc.
  • Sameer LalSenior Vice President - Business Development of Indegene, Inc.
  • Rajesh NairNon-Executive Director, President of Indegene, Inc.
Indegene Share Price FAQs

Indegene is trading at 662.30 as on Mon Nov 16 2026 09:59:00. This is -0.47% lower as compared to its previous closing price of 665.45.

The market capitalization of Indegene is 15959.47 Cr as on Mon Nov 16 2026 09:59:00.

The average broker rating on Indegene is Hold. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 3 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 1 analysts have given a strong sell rating

The 52 wk high for Indegene is 677.00 whereas the 52 wk low is 414.90

Indegene can be analyzed on the following key metrics -

  • TTM P/E: 34.51
  • Sector P/E: 43.19
  • Dividend Yield: 0.34%
  • D/E ratio: 0.05

Indegene reported a net profit of 401.10 Cr in 2026.

The Mutual Fund Shareholding was 12.25% at the end of 30 Sep 2026.